Trials / Sponsors / Semafore Pharmaceuticals
Semafore Pharmaceuticals
Industry · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion in Patien Advanced or Metastatic Solid Tumors, Cancer, Solid Cancers | Phase 1 | 2007-04-01 |